Items such as nuts, edamame, dried fruit, or protein bars provide a healthy option if hunger strikes
Conclusion: This meta-analysis demonstrates that GLP-1 receptor agonists are a promising therapeutic option for patients with IIH, demonstrating significant efficacy in reducing intracranial pressure-related symptoms such as BMI, headache frequency, papilledema, and visual disturbances
Research shows that GLP-1 medications can delay this weight loss plateau compared to diet alone, but eventually, most people will hit a wall
Cochrane Metabolic and Endocrine Disorders Group, ed
GLP-1 agonists/analogues show beneficial effects on most of the multiple alterations underlying MASLD and cirrhosis progression [10]